关键词：痤疮；皮肤；炎性病症；确切病因
摘 要：Acne or acne vulgaris is an inflammatory disorder of the skin which affects people of almost all age groups. The exact etiology of acne is not fully understood. Although acne does not present a serious threat to health, severe acne can not only be painful but also affect a person’s quality of life. Topical medications, oral medications, or a combination of both are some of the treatment options available for acne.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

07. Implications of Acne

07.1 Five Forces Analysis

08. Types and Characteristics of Acne

09. Competitive Assessment of Marketed

Products

10. Rate of Incidence and Prevalence

10.1.1 US

10.1.2 UK

11. Market Segmentation by Category

12. Geographical Segmentation

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

20.1 Competitive Scenario

20.1.1 Key News

20.1.2 Mergers and Acquisitions

20.2 Market Share Analysis 2013

20.3 Other Prominent Vendors

21. Key Vendor Analysis

21.1 Actavis

21.1.1 Key Facts

21.1.2 Business Description

21.1.3 Business Segmentation

21.1.4 Business Segmentation by Revenue 2012 and 2013

21.1.5 Sales by Geography

21.1.6 Business Strategy

21.1.7 Key Information

21.1.8 SWOT Analysis

21.2 Allergan

21.2.1 Key Facts

21.2.2 Business Description

21.2.3 Business Segmentation

21.2.4 Business Segmentation by Revenue

21.2.5 Business Segmentation by Revenue 2011-2013

21.2.6 Geographical Segmentation by Revenue 2013

21.2.7 Business Strategy

21.2.8 Key Developments

21.2.9 SWOT Analysis

21.3 Galderma

21.3.1 Key Facts

21.3.2 Business Overview

21.3.3 Product Segmentation by Revenue 2013

21.3.4 Geographical Segmentation by Revenue 2013

21.3.5 Business Strategy

21.3.6 Recent Developments

21.3.7 SWOT Analysis

21.4 Stiefel Laboratories

21.4.1 Key Facts

21.4.2 Business Overview

21.4.3 Product Segmentation

21.4.4 Geographical Segmentation

21.4.5 Business Strategy

21.4.6 Recent Developments

21.4.7 SWOT Analysis

21.5 Valeant Pharmaceuticals International

21.5.1 Key Facts

21.5.2 Business Overview

21.5.3 Business Segmentation by Revenue 2013

21.5.4 Business Segmentation by Revenue 2012 and 2013

21.5.5 Sales by Geography

21.5.6 Business Strategy

21.5.7 Key Developments

21.5.8 SWOT Analysis

22. Other reports in this Series